LYONS GARY A sold 12.2% of their position (8K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $328.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2026ACC: 0001123343-26-000002
+8K
Net shares
Net buyer
$328.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16K acquired · 8K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8K
Price / share
$16.33
Trade value
$130.64K
% of position
13.9%
4/14/2026
57.50K→65.50K
Common Stock
Direct
Shares
−8K
Price / share
$41.07
Trade value
$328.56K
% of position
12.2%
4/14/2026
65.50K→57.50K
Total
Net shares
+0.00
Net value
-$197.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/14/2026 | M · Option Exercise | +8K | $16.33 | $130.64K | 13.9% | 57.50K | 65.50K |
| Common Stock Direct | 4/14/2026 | S · Sale | −8K | $41.07 | $328.56K | 12.2% | 65.50K | 57.50K |
| Total | +0.00 | -$197.92K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
8K shares
Shares
+8K
Strike price
16.33
Held after
0.00
Exercisable
—
4/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock8K shares | 4/14/2026 | M · Option Exercise | +8K | 16.33 | — | 0.00 |